Our capital expenditures for the three and six months ended June 30, 2008 and 2007 were as follows (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2008			2007			2008			2007
Type
Recurring	$	7,495		$	7,921		$	14,692		$	14,146
Reimbursements		(881	)		(872	)		(2,041	)		(872	)
Net recurring		6,614			7,049			12,651			13,274
Corporate(1)		3,425			3,219			7,339			9,198
EBITDA-enhancing(2)		11,089			14,619			25,010			25,010
Development(3)		19,446			8,843			40,627			20,579
Net Total Capital Expenditures	$	40,574		$	33,730		$	85,627		$	68,061

(1)   Corporate primarily includes capital expenditures for information technology systems and equipment.

(2)   EBITDA-enhancing capital expenditures generally represent unusual or non-recurring capital items and/or major renovations.

(3)   Development capital expenditures primarily relate to the facility expansion and de novo development program.